Form S-1/A Tvardi Therapeutics,
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20251007/A4BZ922C8Z22KJZZ27ZO2ZZZDPT9Z2R2ZV7Q
Filed on: October 7, 2025
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Tvardi Therapeutics Inc (TVRD)
- Zipalertinib trial data to be presented at IASLC lung cancer conference
- Silver Bow Mining restores underground access at Montana silver-zinc site
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
